Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1328600
Reference Type
Journal Article
Title
Curcumin attenuates DNB-induced murine colitis
Author(s)
Salh, B; Assi, K; Templeman, V; Parhar, K; Owen, D; Gómez-Muñoz, A; Jacobson, K
Year
2003
Is Peer Reviewed?
Yes
Journal
American Journal of Physiology: Gastrointestinal and Liver Physiology
ISSN:
0193-1857
EISSN:
1522-1547
Volume
285
Issue
1
Page Numbers
G235-G243
Language
English
PMID
12637253
DOI
10.1152/ajpgi.00449.2002
Web of Science Id
WOS:000183399900026
Abstract
Numerous therapies used for inflammatory bowel disease (IBD) target the transcription factor NF-kappaB, which is involved in the production of cytokines and chemokines integral for inflammation. Here we show that curcumin, a component of the spice turmeric, is able to attenuate colitis in the dinitrobenzene sulfonic acid (DNB)-induced murine model of colitis. When given before the induction of colitis it reduced macroscopic damage scores and NF-kappaB activation. This was accompanied by a reduction in myeloperoxidase activity, and using semiquantitative RT-PCR, an attenuation of the DNB-induced message for IL-1beta was detected. Western blotting analysis revealed that there was a reproducible DNB-induced activation of p38 MAPK detected in intestinal lysates by using a phosphospecific antibody. This signal was significantly attenuated by curcumin. Furthermore, we show that the immunohistochemical signal is dramatically attenuated at the level of the mucosa by curcumin. We conclude that the widely used food additive curcumin is able to attenuate experimental colitis through a mechanism correlated with the inhibition of the activation of NF-kappaB and effects a reduction in the activity of p38 MAPK. We propose that this agent may have therapeutic implications for human IBD.
Keywords
inflammatory bowel disease; nuclear factor-kappa B; p38 MAPK
Tags
PPRTV
•
1,3-Dinitrobenzene 2021
Literature Search June 2021
PubMed
Scopus (July 2021)
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity